Johnson & Johnson
At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow and profoundly impact health for humanity.
Net income compounded at 10.0% annually over 6 years.
Current Price
$243.04
-0.44%GoodMoat Value
$210.09
13.6% overvaluedJohnson & Johnson (JNJ) DCF Calculator
What is a DCF Calculator?
A Discounted Cash Flow (DCF) model estimates a company's intrinsic value by projecting its future cash flows and discounting them back to the present. The core idea: a dollar earned in the future is worth less than a dollar today.
Inputs
Cash flow, discount rate, terminal growth & projection years
Model
Projects cash flows forward, adds terminal value, discounts back
Output
Intrinsic value per share — compare with price for margin of safety
Enter a ticker on the left to auto-fill real financial data and get started.
JNJ DCF Calculator — Discounted Cash Flow
Discounted Cash Flow (DCF) calculator for Johnson & Johnson (JNJ). Estimate the intrinsic value of JNJ stock by projecting future cash flows and discounting them to present value. The two-stage DCF model supports EPS-based, FCF-based, and dividend-based approaches.
Current EPS: $11.03. Free cash flow: $19.70B. FCF growth rate: -0.18%. WACC: 10.00%. Shares outstanding: 2409.3M. GoodMoat fair value: $210.09.
The DCF calculator projects 10 years of cash flows at a user-adjustable growth rate, applies a terminal growth rate, and discounts all future cash flows back to present value using the weighted average cost of capital (WACC). A sensitivity table shows how the intrinsic value changes across different growth and discount rate assumptions. Use this tool alongside GoodMoat's reverse DCF and fair value models to triangulateJohnson & Johnson's true worth.